Is Trip.com (TCOM) a Buy as Wall Street Analysts Look Optimistic?

Trip.com (TCOM) currently exhibits significant analyst optimism with an Average Brokerage Recommendation (ABR) of 1.25, derived from 17 Strong Buy ratings among 20 firms. While cautioning against the inherent positive bias in ABRs, the article emphasizes TCOM's strong fundamental outlook, citing a 5.1% increase in its Zacks Consensus Estimate for current year EPS to $3.69 over the past month. This upward revision in earnings estimates has resulted in a Zacks Rank #1 (Strong Buy) for TCOM, indicating strong near-term price performance potential driven by earnings estimate revisions, with the ABR serving as a corroborating indicator.

Analysis

Trip.com (TCOM) is exhibiting strong bullish signals from sell-side analysts, evidenced by an Average Brokerage Recommendation (ABR) of 1.25 on a 1-to-5 scale. This score is derived from 20 brokerage firms, of which 17 rate the stock a "Strong Buy" and one a "Buy," representing a 90% positive consensus. More fundamentally, this optimism is substantiated by recent upward revisions in earnings estimates. The Zacks Consensus Estimate for TCOM's current-year EPS has increased 5.1% over the past month to $3.69. This trend of positive earnings estimate revisions is a key driver, leading to the stock being assigned a Zacks Rank #1 (Strong Buy). While analyst recommendations can carry an inherent positive bias, the alignment with a quantitative, earnings-driven indicator suggests the positive outlook for TCOM is rooted in improving earnings prospects rather than just sentiment.

Key Decisions for Investors

• The convergence of a highly favorable sell-side consensus (1.25 ABR) with a quantitative Strong Buy rating based on earnings revisions presents a compelling bullish signal for TCOM.
• Investors should focus on the trend in earnings estimate revisions as the primary driver of this thesis; the recent 5.1% increase in the consensus EPS to $3.69 is the key metric to monitor for continued strength.
• Given that the analysis highlights the superiority of earnings revisions over simple analyst ratings, positions should be predicated on the continuation of this positive earnings outlook, using the ABR as a secondary, corroborating data point.